✨ Free AI Report
Glenmark Pharmaceuticals Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Glenmark Pharmaceuticals Limited
Company Research

Glenmark Pharmaceuticals Limited: Business Overview, Financials & Competitive Analysis

Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, founded in 1977. The company develops, manufactures, and sells generics, specialty medicines, and over the co...

Analyst-debate audio for Glenmark Pharmaceuticals Limited

AskCyborg analysts argue the bull and bear cases for Glenmark Pharmaceuticals Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Mixed

Cyborg Score thesis

Glenmark presents a growth opportunity in emerging pharma with strong domestic momentum, but recent regulatory setbacks create...

Read the full analyst-debate transcript →
Industry Pharmaceuticals - Generics, Specialty & Innovative Medicines
4 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Glenmark Pharmaceuticals Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Glenmark Pharmaceuticals Limited Overview

Pro stress-test →

Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, founded in 1977. The company develops, manufactures, and sells generics, specialty medicines, and over the counter pharmaceutical products across India, North America, Europe, and internationally. Glenmark focuses on developing products in respiratory, dermatology, and oncology therapy areas.

Strategic Profile

Pro stress-test →

The company reported consolidated revenue growth of 15.1% year-over-year for Q3 FY26, with significant contributions from the India formulation business which grew by 22.1%. Glenmark launched innovative products including NEBZMART GFB Smartules and Glenmark AIRZ FB Smartules, marking the world's first nebulized fixed-dose triple therapy for COPD. The company's Monroe manufacturing site is scheduled to begin commercial production in Q4 FY26, supporting its systematic regulatory filing strategy in the North American generic pharmaceuticals market.

Competitive Landscape

Pro stress-test →

Glenmark competes across multiple therapeutic areas including dermatology, respiratory, oncology, and specialty generics. The company faces competition from global pharma giants and regional Indian pharmaceutical manufacturers. Its differentiation lies in complex injectables, respiratory products, and dermatology innovation, though regulatory challenges present competitive vulnerabilities.

Industry Context

Glenmark Pharmaceuticals Limited operates in Pharmaceuticals - Generics, Specialty & Innovative Medicines.

Key facts

Founded: 1977 · Headquarters: Mumbai, India · Employees: 12,736 · Revenue: $1.25B+ (FY2017, recent figures in INR) · Market cap: $6.6B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Glenmark Pharmaceuticals Limited.

  • India formulation business growth of 22.1% in Q3 FY26 demonstrates strong domestic market execution
  • Global innovative portfolio RYALTRIS has been commercialized in 52 markets with marketing applications in over 90 countries
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • July 2025Ichnos Glenmark Innovation entered into a global licensing agreement with AbbVie for development and commercialization
  • August 2025Glenmark announced the transfer of its consumer care business into a newly incorporated wholly owned subsidiary
  • +2 moreTrack every material event for Glenmark Pharmaceuticals Limited as it happens. Explore monitoring →
Get alerted when Glenmark Pharmaceuticals Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

MerckDiversified global pharmaceutical company→Dr. Reddy's LaboratoriesIndian pharma competitor in generics and specialty→CiplaMajor Indian pharmaceutical manufacturer→LupinIndian pharma company in generics and respiratory→

Compare Glenmark Pharmaceuticals Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Glenmark Pharmaceuticals Limited operates in Pharmaceuticals - Generics, Specialty & Innovative Medicines. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals - Generics, Specialty & Innovative Medicines research →
NEW · MCP server

Ask your AI assistant about Glenmark Pharmaceuticals Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Glenmark Pharmaceuticals Limited and its top competitor on Cyborg Score”
“What did Glenmark Pharmaceuticals Limited do this quarter?”
“Is Glenmark Pharmaceuticals Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Glenmark Pharmaceuticals Limited do?+
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, founded in 1977. The company develops, manufactures, and sells generics, specialty medicines, and over the co...
What is Glenmark Pharmaceuticals Limited's Cyborg Score?+
Glenmark Pharmaceuticals Limited has a Cyborg Score of 6/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Glenmark Pharmaceuticals Limited's main competitors?+
Named competitors include Merck, Dr. Reddy's Laboratories, Cipla, Lupin. The full competitive landscape is in the AskCyborg report.
How can I get the full Glenmark Pharmaceuticals Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Glenmark Pharmaceuticals Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Glenmark Pharmaceuticals Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals - Generics research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Cipla Limited6Glenmark Pharmaceuticals Limited7Merck & Co., Inc.7Lupin Limited